PHARMALA BIOTECH HOLDINGS INC. financial statements, including revenue, expenses, profit, and loss

The total revenue of MDMA for the last quarter is 139.85 k CAD, and it's 54.67% higher compared to the previous quarter. The net income of Q3 24 is -413.15 k CAD.